Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2020 Jan 1;83(1):90–98. doi: 10.1097/QAI.0000000000002233

Figure 3: Extracellular vesicles from HIV-infected ART-suppressed donors contain ARV drugs.

Figure 3:

EVs were isolated from HIV-positive ART-suppressed donors’ plasma (ART-BE) and semen (ART-SE). Drug concentrations were measured by LC-MS/MS from 4 donors with similar drug regimen. ARVs are denoted as (A) TFV (tenofovir), (B) FTC (emtricitabine), (C) DTG (dolutegravir), (D) EFV (efavirenz). Broken lines indicate FDA-half maximal inhibitory concentrations (IC50) for HIV-1.